-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LvomAmtfXF27mIs+oKXOfW+6E/aU4FDfzLNlN+A0+VDwxeZMGip1FCPYxO6HQpui aBU/z60M+6U34uDDAl2M+A== 0000950116-03-004604.txt : 20031119 0000950116-03-004604.hdr.sgml : 20031119 20031119172521 ACCESSION NUMBER: 0000950116-03-004604 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031118 FILED AS OF DATE: 20031119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERRI ROSE C CENTRAL INDEX KEY: 0001125858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 031013744 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQUARE STE 202 STREET 2: TORONTO ONTARIO CITY: CANADA M5H2G2 STATE: A1 ZIP: 00000 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: C/O GENEREX BIOTECHNOLOGY CORP STREET 2: 33 HARBOR SQUARE STE 202 TORONTO ONTARIO CITY: CANADA M5J2G2 4 1 p328307_ex.xml FORM 4 X0201 4 2003-11-18 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001125858 PERRI ROSE C 33 HARBOUR SQUARE, SUITE 202 TORONTO A6 M5H 2G2 1 1 1 0 COO, Acting CFO, Secretary Common Stock 2003-11-18 4 P 0 500 1.65 A 203626 D Common Stock 341496 I By EBI, Inc. Common Stock 1651246 I By Estate of Mark Perri Common Stock 953667 I By GHI, Inc. Rose C. Perri 2003-11-19 -----END PRIVACY-ENHANCED MESSAGE-----